Want to see AU:HCT full AI Analyst Report?
HCT Stock Chart & Stats
AU$0.09
<AU$0.01(10.00%)
At close: 4:00 PM EST
AU$0.09
<AU$0.01(10.00%)
Day’s Range― - ―
52-Week RangeAU$0.05 - AU$0.11
Previous CloseN/A
Volume829.52K
Average Volume (3M)99.55K
Market Cap
AU$18.02M
Enterprise ValueAU$22.05
Total Cash (Recent Filing)AU$2.16M
Total Debt (Recent Filing)AU$1.59M
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Mar 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding367,834,350
10 Day Avg. Volume31,921
30 Day Avg. Volume99,550
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)28.04
Price to Sales (P/S)5.45
P/FCF Ratio-20.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Equity RestorationA return to positive equity improves the company’s solvency position relative to prior years and provides a stronger base for restructuring, funding operations, and supporting future commercialisation.
Gross Margin ImprovementThe sharp year-over-year gross-margin improvement indicates that product economics can improve when the business mix or production execution is favourable, although sustained gains are needed to support profitability.
Integrated Health Product PlatformControl across research, manufacturing, and distribution can help coordinate product development and commercialisation, while the natural-health focus provides multiple avenues for future nutraceutical and functional-product expansion.
Bears Say
Severe Revenue ContractionThe latest revenue contraction signals weak demand, distribution, or operating continuity and reduces the scale available to absorb fixed costs, making a durable recovery in sales essential to restoring earnings quality.
Persistent Cash BurnRepeated negative operating and free cash flow means the business is not funding itself internally, increasing dependence on external capital and leaving less flexibility to invest in products, manufacturing, or growth.
High Leverage And LossesMeaningful debt alongside substantial losses limits financial flexibility and raises funding risk. Unless profitability improves materially, interest and operating commitments could constrain investment and shareholder value.
Holista Colltech Limited News
HCT FAQ
What was Holista Colltech Limited’s price range in the past 12 months?
Holista Colltech Limited lowest share price was AU$0.05 and its highest was AU$0.11 in the past 12 months.
What is Holista Colltech Limited’s market cap?
Holista Colltech Limited’s market cap is AU$18.02M.
When is Holista Colltech Limited’s upcoming earnings report date?
Holista Colltech Limited’s upcoming earnings report date is Mar 03, 2027 which is in 181 days.
How were Holista Colltech Limited’s earnings last quarter?
Holista Colltech Limited released its earnings results on Aug 31, 2026. The company reported -AU$0.007 earnings per share for the quarter.
Is Holista Colltech Limited overvalued?
According to Wall Street analysts Holista Colltech Limited’s price is currently Overvalued.
Does Holista Colltech Limited pay dividends?
Holista Colltech Limited does not currently pay dividends.
What is Holista Colltech Limited’s EPS estimate?
Holista Colltech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Holista Colltech Limited have?
Holista Colltech Limited has 367,834,350 shares outstanding.
What happened to Holista Colltech Limited’s price movement after its last earnings report?
Holista Colltech Limited reported an EPS of -AU$0.007 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Holista Colltech Limited?
Currently, no hedge funds are holding shares in AU:HCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Holista Colltech Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:HCT Sentiment 67%
Sector Average 56%
Sector Average 56%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.45%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
4.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Holista Colltech Limited
Holista CollTech Limited is a biotechnology firm with operations spanning Australia, Malaysia, and the United States. Its business activities are organized into four key divisions: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The company specializes in the production and distribution of dietary supplements, cosmetic-quality collagen, and a variety of health-conscious food ingredients. These innovative food products include low-glycemic index (GI) flour blends suitable for noodles, pasta, flatbreads, and other baked goods, along with low-sodium salt, reduced-fat fried options, and both less-calorie and low-GI sugar alternatives. Furthermore, Holista CollTech offers solutions for infection control. Its corporate headquarters are located in Subiaco, Australia.
Technical Analysis
Noumi Limited
―
Bioxyne Limited
―
Bubs Australia Ltd.
―
Nutritional Growth Solutions Ltd.
―
Clover Corporation Limited
―